By Leah Douglas WASHINGTON, March 12 (Reuters) - Compounded weight-loss drugs that contain vitamin B12 and the main ingredient in Eli Lilly's Zepbound could present health risks to consumers due to a ...
Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...
Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral ...
INDIANAPOLIS (WISH) — Indianapolis-based Lilly said Thursday its daily obesity pill, orforglipron, has shown “positive results” in a late-stage trial. Patients taking orforglipron, an oral GLP-1 ...
GLP-1s have been the blockbuster biopharma story of the past few years, and these effective weight loss drugs will forever be the watershed moment in the long fight against obesity. Not to be ...
Spread the loveThe healthcare sector continues to draw attention from investors, particularly as advancements in pharmaceuticals and medical innovations unfold. As of March 8, 2026, MarketBeat's stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results